title: Evaluation of lymphocyte apoptosis in dogs with inflammatory bowel disease.
abstract: OBJECTIVE
  To determine whether lymphocyte apoptosis in intestinal mucosae is more common in healthy dogs than dogs with inflammatory bowel disease (IBD) and whether numbers of apoptotic cells increase after successful treatment of affected dogs.
  
  
  METHODS
  8 dogs with IBD (IBD dogs) and 8 healthy control dogs.
  
  
  METHODS
  Biopsy specimens of the duodenum and colon were obtained via endoscopy from dogs with IBD before and after 10 weeks of standard treatment and compared with specimens obtained from control dogs. Expression of activated caspase 3 (Casp3), caspase-cleaved fragment p85 from poly-ADP-ribose polymerase (PARP), and B-cell leukemia/lymphoma 2 (Bcl-2) was measured in the duodenal (villous tip and base) and colonic mucosae.
  
  
  RESULTS
  Expression of Casp3 was greater in the duodenal villous tips of control dogs, compared with expression in similar tissues from dogs with IBD before or after treatment. Despite clinical improvement of dogs with IBD, expression of Casp3 did not increase after treatment. Expression of PARP did not differ between groups at any time point. Expression of Bcl-2 was greater at all 3 tissue sites in control dogs, compared with expression at the same sites in dogs with IBD. Furthermore, Bcl-2 expression in duodenal villous tips was higher in dogs with IBD after treatment but was not higher elsewhere. In control dogs, expression patterns for all 3 markers were similar between sites (villous tip > villous base > colon).
  
  
  CONCLUSIONS
  Expression of Casp3 in lymphocytes in duodenal villous tips was significantly reduced in dogs with IBD, compared with expression in healthy dogs, but no increase was detected following successful treatment of IBD. Increased expression of Bcl-2 may be a potential marker of the success of treatment.
authors.affiliation: Division of Small Animal Internal Medicine, Vetsuisse Faculty of the University of Bern, Bern, Switzerland.
authors.forename: Julien R
authors.initials: JR
authors.lastname: Dandrieux
authors.forename: Valérie F
authors.initials: VF
authors.lastname: Bornand
authors.forename: Marcus G
authors.initials: MG
authors.lastname: Doherr
authors.forename: Rui
authors.initials: R
authors.lastname: Kano
authors.forename: Andreas
authors.initials: A
authors.lastname: Zurbriggen
authors.forename: Iwan A
authors.initials: IA
authors.lastname: Burgener
mesh_terms: D000818:Animals; D017209:Apoptosis; D001706:Biopsy; D053148:Caspase 3 / Q000378:metabolism; D003106:Colon / Q000166:cytology / Q000473:pathology; D003113:Colonoscopy; D004283:Dog Diseases / Q000473:pathology*; D004285:Dogs; D004386:Duodenum / Q000166:cytology / Q000473:pathology; D004724:Endoscopy; D007150:Immunohistochemistry; D015212:Inflammatory Bowel Diseases / Q000473:pathology / Q000662:veterinary*; D007413:Intestinal Mucosa / Q000473:pathology; D008214:Lymphocytes / Q000166:cytology / Q000473:pathology*; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism; D012016:Reference Values; D013270:Stomach / Q000473:pathology
chemical_list: D011065:Poly(ADP-ribose) Polymerases; D053148:Caspase 3